|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
Fine-mapping of the GWAS signal region led to the identification of twenty SNPs that showed a stronger association with bladder cancer risk than rs710521.
|
29956121 |
2018 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
Fine-mapping of the GWAS signal region led to the identification of twenty SNPs that showed a stronger association with bladder cancer risk than rs710521.
|
29956121 |
2018 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
GWASDB |
Genome-wide association study identifies multiple loci associated with bladder cancer risk.
|
24163127 |
2014 |
|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
Genome-wide association studies have confirmed association of TP63C/T rs710521, TERTC/T rs2736098, and SLC14A1C/T rs17674580 gene variants with susceptibility to bladder cancer (BC) in European and White population.
|
25218484 |
2014 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
Genome-wide association studies have confirmed association of TP63C/T rs710521, TERTC/T rs2736098, and SLC14A1C/T rs17674580 gene variants with susceptibility to bladder cancer (BC) in European and White population.
|
25218484 |
2014 |
|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
GWASCAT |
Genome-wide association study identifies multiple loci associated with bladder cancer risk.
|
24163127 |
2014 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
GWASDB |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
GWASDB |
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
|
20348956 |
2010 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
Performing a meta-analysis of 5,695 cases and 40,187 controls including all published studies on rs710521, a convincing association with bladder cancer risk was obtained (OR = 1.18; 95% Cl = 1.12-1.25; P < 0.0001).
|
21063684 |
2010 |
|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
GWASCAT |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
20972438 |
2010 |
|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
GWASCAT |
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
|
20348956 |
2010 |
|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
Performing a meta-analysis of 5,695 cases and 40,187 controls including all published studies on rs710521, a convincing association with bladder cancer risk was obtained (OR = 1.18; 95% Cl = 1.12-1.25; P < 0.0001).
|
21063684 |
2010 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
We genotyped rs9642880 G>T on 8q24 and rs710521</span> A>G on 3q28 in a two-stage case-control study of bladder cancer to evaluate the association and further examined the expression of MYC.
|
19369583 |
2009 |
|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
BEFREE |
We genotyped rs9642880 G>T on 8q24 and rs710521</span> A>G on 3q28 in a two-stage case-control study of bladder cancer to evaluate the association and further examined the expression of MYC.
|
19369583 |
2009 |
|
Malignant neoplasm of urinary bladder
|
|
0.740 |
GeneticVariation
|
GWASDB |
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.
|
18794855 |
2008 |
|
Carcinoma of bladder
|
|
0.740 |
GeneticVariation
|
GWASCAT |
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.
|
18794855 |
2008 |
|
Nasopharyngeal carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.
|
20512145 |
2010 |
|
Bladder Neoplasm
|
|
0.040 |
GeneticVariation
|
BEFREE |
Fine-mapping of the GWAS signal region led to the identification of twenty SNPs that showed a stronger association with bladder cancer risk than rs710521.
|
29956121 |
2018 |
|
Bladder Neoplasm
|
|
0.040 |
GeneticVariation
|
BEFREE |
Genome-wide association studies have confirmed association of TP63C/T rs710521, TERTC/T rs2736098, and SLC14A1C/T rs17674580 gene variants with susceptibility to bladder cancer (BC) in European and White population.
|
25218484 |
2014 |
|
Bladder Neoplasm
|
|
0.040 |
GeneticVariation
|
BEFREE |
Performing a meta-analysis of 5,695 cases and 40,187 controls including all published studies on rs710521, a convincing association with bladder cancer risk was obtained (OR = 1.18; 95% Cl = 1.12-1.25; P < 0.0001).
|
21063684 |
2010 |
|
Bladder Neoplasm
|
|
0.040 |
GeneticVariation
|
BEFREE |
We genotyped rs9642880 G>T on 8q24 and rs710521</span> A>G on 3q28 in a two-stage case-control study of bladder cancer to evaluate the association and further examined the expression of MYC.
|
19369583 |
2009 |